Bioactive proteins and peptides are considered as important ingredients in functional foods, nutraceuticals and personal care. The roles of bioactive proteins and peptides include antioxidant, antimicrobial, antihypertensive, immunomodulatory and other biological activities.
This report studies and analyses global Bioactive Protein and Peptides status and future trends, to help determine the Bioactive Protein and Peptides market size of the total market opportunity by Source, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Bioactive Protein and Peptides, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Market Report Coverage
(1) Global Bioactive Protein and Peptides market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Bioactive Protein and Peptides by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Bioactive Protein and Peptides by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Bioactive Protein and Peptides key consuming regions, consumption value and demand structure
(5) Bioactive Protein and Peptides industry chains, upstream, midstream and downstream
According to Latest Study, the global market for Bioactive Protein and Peptides should grow from US$ 1695.8 million in 2022 to US$ 2706.1 million by 2029, with a CAGR of 6.9% for the period of 2023-2029..
Global key players of bioactive protein and peptides include Gelita, Kerry Group, Vital Proteins, Rousselot, BRF Ingredients, etc. The top five players hold a share over 50%. North America is the largest market, has a share about 40%, followed by Europe, and Asia-Pacific, with share 30% and 20%, separately.
Market segment by players, this report covers
Gelita
Kerry Group
Vital Proteins
Rousselot
BRF Ingredients
Bunge Ltd
Ingredia Nutritional
Gelatines Weishardt
PanTheryx
Hubei Reborn Biotech
Seagarden
Shandong Hengxin Biotech
Baotou Dongbao Bio-Tech
Wuhan Jiushengtang Biotech
Morinaga Milk
Collagile
Nuritas
SmartPEP
Market segment by Source, covers
Plant Source
Animal Source
Market segment by Application, can be divided into
Functional Food
Dietary Supplements
Personal Care
Animal Nutrition
Other
Overview of the regional outlook of the Market:
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
The report provides insights on the following pointers:
Chapter 1: to describe Bioactive Protein and Peptides product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Bioactive Protein and Peptides market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Bioactive Protein and Peptides market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Bioactive Protein and Peptides industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Source, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
1 Market Overview
1.1 Bioactive Protein and Peptides Definition
1.2 Global Bioactive Protein and Peptides Market Size and Forecast
1.3 China Bioactive Protein and Peptides Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Bioactive Protein and Peptides Market Size: China VS Global Growth Rate, 2018-2029
1.6 Bioactive Protein and Peptides Market Dynamics
1.6.1 Bioactive Protein and Peptides Market Drivers
1.6.2 Bioactive Protein and Peptides Market Restraints
1.6.3 Bioactive Protein and Peptides Industry Trends
1.6.4 Bioactive Protein and Peptides Industry Policy
2 Global Leading Players and Market Share
2.1 By Revenue of Bioactive Protein and Peptides, Global Market Share by Company, 2018-2023
2.2 Global Bioactive Protein and Peptides Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Bioactive Protein and Peptides Concentration Ratio
2.4 Global Bioactive Protein and Peptides Mergers & Acquisitions, Expansion Plans
2.5 Global Bioactive Protein and Peptides Major Companies Product Type
2.6 Head Office and Bioactive Protein and Peptides Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Bioactive Protein and Peptides, China Market Share by Company, 2018-2023
3.2 China Bioactive Protein and Peptides Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
4.1 Bioactive Protein and Peptides Industry Chain
4.2 Bioactive Protein and Peptides Upstream Analysis
4.2.1 Bioactive Protein and Peptides Core Raw Materials
4.2.2 Main Manufacturers of Bioactive Protein and Peptides Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Bioactive Protein and Peptides Production Mode
4.6 Bioactive Protein and Peptides Procurement Model
4.7 Bioactive Protein and Peptides Industry Sales Model and Sales Channels
4.7.1 Bioactive Protein and Peptides Sales Model
4.7.2 Bioactive Protein and Peptides Typical Distributors
5 Sights by Source
5.1 Bioactive Protein and Peptides Classification
5.1.1 Plant Source
5.1.2 Animal Source
5.2 By Source, Global Bioactive Protein and Peptides Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Source, Global Bioactive Protein and Peptides Consumption Value, 2018-2029
6 Sights by Application
6.1 Bioactive Protein and Peptides Segment by Application
6.1.1 Functional Food
6.1.2 Dietary Supplements
6.1.3 Personal Care
6.1.4 Animal Nutrition
6.1.5 Other
6.2 By Application, Global Bioactive Protein and Peptides Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Bioactive Protein and Peptides Consumption Value, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Bioactive Protein and Peptides Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Bioactive Protein and Peptides Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Bioactive Protein and Peptides & Forecasts, 2018-2029
7.3.2 By Country, North America Bioactive Protein and Peptides Market Size Market Share
7.4 Europe
7.4.1 Europe Bioactive Protein and Peptides Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Bioactive Protein and Peptides Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Bioactive Protein and Peptides Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Bioactive Protein and Peptides Market Size Market Share
7.6 South America
7.6.1 South America Bioactive Protein and Peptides Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Bioactive Protein and Peptides Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level
8.1 By Country, Global Bioactive Protein and Peptides Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Bioactive Protein and Peptides Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Bioactive Protein and Peptides Market Size, 2018-2029
8.3.2 By Source, U.S. Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
8.3.3 By Application, U.S. Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Bioactive Protein and Peptides Market Size, 2018-2029
8.4.2 By Source, Europe Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
8.4.3 By Application, Europe Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
8.5 China
8.5.1 China Bioactive Protein and Peptides Market Size, 2018-2029
8.5.2 By Source, China Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
8.5.3 By Application, China Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Bioactive Protein and Peptides Market Size, 2018-2029
8.6.2 By Source, Japan Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
8.6.3 By Application, Japan Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Bioactive Protein and Peptides Market Size, 2018-2029
8.7.2 By Source, South Korea Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
8.7.3 By Application, South Korea Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Bioactive Protein and Peptides Market Size, 2018-2029
8.8.2 By Source, Southeast Asia Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
8.8.3 By Application, Southeast Asia Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Bioactive Protein and Peptides Market Size, 2018-2029
8.9.2 By Source, India Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
8.9.3 By Application, India Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
8.10 Middle East & Africa
8.10.1 Middle East & Africa Bioactive Protein and Peptides Market Size, 2018-2029
8.10.2 By Source, Middle East & Africa Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
8.10.3 By Application, Middle East & Africa Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
9 Company Profile
9.1 Gelita
9.1.1 Gelita Company Information, Head Office, Market Area and Industry Position
9.1.2 Gelita Company Profile and Main Business
9.1.3 Gelita Bioactive Protein and Peptides Models, Specifications and Application
9.1.4 Gelita Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023
9.1.5 Gelita Recent Developments
9.2 Kerry Group
9.2.1 Kerry Group Company Information, Head Office, Market Area and Industry Position
9.2.2 Kerry Group Company Profile and Main Business
9.2.3 Kerry Group Bioactive Protein and Peptides Models, Specifications and Application
9.2.4 Kerry Group Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023
9.2.5 Kerry Group Recent Developments
9.3 Vital Proteins
9.3.1 Vital Proteins Company Information, Head Office, Market Area and Industry Position
9.3.2 Vital Proteins Company Profile and Main Business
9.3.3 Vital Proteins Bioactive Protein and Peptides Models, Specifications and Application
9.3.4 Vital Proteins Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023
9.3.5 Vital Proteins Recent Developments
9.4 Rousselot
9.4.1 Rousselot Company Information, Head Office, Market Area and Industry Position
9.4.2 Rousselot Company Profile and Main Business
9.4.3 Rousselot Bioactive Protein and Peptides Models, Specifications and Application
9.4.4 Rousselot Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023
9.4.5 Rousselot Recent Developments
9.5 BRF Ingredients
9.5.1 BRF Ingredients Company Information, Head Office, Market Area and Industry Position
9.5.2 BRF Ingredients Company Profile and Main Business
9.5.3 BRF Ingredients Bioactive Protein and Peptides Models, Specifications and Application
9.5.4 BRF Ingredients Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023
9.5.5 BRF Ingredients Recent Developments
9.6 Bunge Ltd
9.6.1 Bunge Ltd Company Information, Head Office, Market Area and Industry Position
9.6.2 Bunge Ltd Company Profile and Main Business
9.6.3 Bunge Ltd Bioactive Protein and Peptides Models, Specifications and Application
9.6.4 Bunge Ltd Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023
9.6.5 Bunge Ltd Recent Developments
9.7 Ingredia Nutritional
9.7.1 Ingredia Nutritional Company Information, Head Office, Market Area and Industry Position
9.7.2 Ingredia Nutritional Company Profile and Main Business
9.7.3 Ingredia Nutritional Bioactive Protein and Peptides Models, Specifications and Application
9.7.4 Ingredia Nutritional Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023
9.7.5 Ingredia Nutritional Recent Developments
9.8 Gelatines Weishardt
9.8.1 Gelatines Weishardt Company Information, Head Office, Market Area and Industry Position
9.8.2 Gelatines Weishardt Company Profile and Main Business
9.8.3 Gelatines Weishardt Bioactive Protein and Peptides Models, Specifications and Application
9.8.4 Gelatines Weishardt Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023
9.8.5 Gelatines Weishardt Recent Developments
9.9 PanTheryx
9.9.1 PanTheryx Company Information, Head Office, Market Area and Industry Position
9.9.2 PanTheryx Company Profile and Main Business
9.9.3 PanTheryx Bioactive Protein and Peptides Models, Specifications and Application
9.9.4 PanTheryx Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023
9.9.5 PanTheryx Recent Developments
9.10 Hubei Reborn Biotech
9.10.1 Hubei Reborn Biotech Company Information, Head Office, Market Area and Industry Position
9.10.2 Hubei Reborn Biotech Company Profile and Main Business
9.10.3 Hubei Reborn Biotech Bioactive Protein and Peptides Models, Specifications and Application
9.10.4 Hubei Reborn Biotech Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023
9.10.5 Hubei Reborn Biotech Recent Developments
9.11 Seagarden
9.11.1 Seagarden Company Information, Head Office, Market Area and Industry Position
9.11.2 Seagarden Company Profile and Main Business
9.11.3 Seagarden Bioactive Protein and Peptides Models, Specifications and Application
9.11.4 Seagarden Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023
9.11.5 Seagarden Recent Developments
9.12 Shandong Hengxin Biotech
9.12.1 Shandong Hengxin Biotech Company Information, Head Office, Market Area and Industry Position
9.12.2 Shandong Hengxin Biotech Company Profile and Main Business
9.12.3 Shandong Hengxin Biotech Bioactive Protein and Peptides Models, Specifications and Application
9.12.4 Shandong Hengxin Biotech Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023
9.12.5 Shandong Hengxin Biotech Recent Developments
9.13 Baotou Dongbao Bio-Tech
9.13.1 Baotou Dongbao Bio-Tech Company Information, Head Office, Market Area and Industry Position
9.13.2 Baotou Dongbao Bio-Tech Company Profile and Main Business
9.13.3 Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Models, Specifications and Application
9.13.4 Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023
9.13.5 Baotou Dongbao Bio-Tech Recent Developments
9.14 Wuhan Jiushengtang Biotech
9.14.1 Wuhan Jiushengtang Biotech Company Information, Head Office, Market Area and Industry Position
9.14.2 Wuhan Jiushengtang Biotech Company Profile and Main Business
9.14.3 Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Models, Specifications and Application
9.14.4 Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023
9.14.5 Wuhan Jiushengtang Biotech Recent Developments
9.15 Morinaga Milk
9.15.1 Morinaga Milk Company Information, Head Office, Market Area and Industry Position
9.15.2 Morinaga Milk Company Profile and Main Business
9.15.3 Morinaga Milk Bioactive Protein and Peptides Models, Specifications and Application
9.15.4 Morinaga Milk Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023
9.15.5 Morinaga Milk Recent Developments
9.16 Collagile
9.16.1 Collagile Company Information, Head Office, Market Area and Industry Position
9.16.2 Collagile Company Profile and Main Business
9.16.3 Collagile Bioactive Protein and Peptides Models, Specifications and Application
9.16.4 Collagile Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023
9.16.5 Collagile Recent Developments
9.17 Nuritas
9.17.1 Nuritas Company Information, Head Office, Market Area and Industry Position
9.17.2 Nuritas Company Profile and Main Business
9.17.3 Nuritas Bioactive Protein and Peptides Models, Specifications and Application
9.17.4 Nuritas Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023
9.17.5 Nuritas Recent Developments
9.18 SmartPEP
9.18.1 SmartPEP Company Information, Head Office, Market Area and Industry Position
9.18.2 SmartPEP Company Profile and Main Business
9.18.3 SmartPEP Bioactive Protein and Peptides Models, Specifications and Application
9.18.4 SmartPEP Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023
9.18.5 SmartPEP Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Table 1. Bioactive Protein and Peptides Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Bioactive Protein and Peptides Market Restraints
Table 3. Bioactive Protein and Peptides Market Trends
Table 4. Bioactive Protein and Peptides Industry Policy
Table 5. Global Bioactive Protein and Peptides Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Bioactive Protein and Peptides Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Bioactive Protein and Peptides Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Bioactive Protein and Peptides Mergers & Acquisitions, Expansion Plans
Table 9. Global Bioactive Protein and Peptides Major Companies Product Type
Table 10. Head Office and Area Served of Key Players
Table 11. China Bioactive Protein and Peptides Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 12. China Bioactive Protein and Peptides Revenue Market Share by Company, 2018-2023
Table 13. Global Key Players of Bioactive Protein and Peptides Upstream (Raw Materials)
Table 14. Global Bioactive Protein and Peptides Typical Customers
Table 15. Bioactive Protein and Peptides Typical Distributors
Table 16. By Source, Global Bioactive Protein and Peptides Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Application, Global Bioactive Protein and Peptides Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Bioactive Protein and Peptides Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 19. By Region, Global Bioactive Protein and Peptides Consumption Value, 2018-2029, US$ Million
Table 20. By Country, Global Bioactive Protein and Peptides Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 21. By Country, Global Bioactive Protein and Peptides Consumption Value, 2018-2029, US$ Million
Table 22. By Country, Global Bioactive Protein and Peptides Consumption Value Market Share, 2018-2029
Table 23. Gelita Company Information, Head Office, Market Area and Industry Position
Table 24. Gelita Company Profile and Main Business
Table 25. Gelita Bioactive Protein and Peptides Models, Specifications, and Application
Table 26. Gelita Bioactive Protein and Peptides Revenue and Gross Margin, US$ Million, 2018-2023
Table 27. Gelita Recent Developments
Table 28. Kerry Group Company Information, Head Office, Market Area and Industry Position
Table 29. Kerry Group Company Profile and Main Business
Table 30. Kerry Group Bioactive Protein and Peptides Models, Specifications, and Application
Table 31. Kerry Group Bioactive Protein and Peptides Revenue and Gross Margin, US$ Million, 2018-2023
Table 32. Kerry Group Recent Developments
Table 33. Vital Proteins Company Information, Head Office, Market Area and Industry Position
Table 34. Vital Proteins Company Profile and Main Business
Table 35. Vital Proteins Bioactive Protein and Peptides Models, Specifications, and Application
Table 36. Vital Proteins Bioactive Protein and Peptides Revenue and Gross Margin, US$ Million, 2018-2023
Table 37. Vital Proteins Recent Developments
Table 38. Rousselot Company Information, Head Office, Market Area and Industry Position
Table 39. Rousselot Company Profile and Main Business
Table 40. Rousselot Bioactive Protein and Peptides Models, Specifications, and Application
Table 41. Rousselot Bioactive Protein and Peptides Revenue and Gross Margin, US$ Million, 2018-2023
Table 42. Rousselot Recent Developments
Table 43. BRF Ingredients Company Information, Head Office, Market Area and Industry Position
Table 44. BRF Ingredients Company Profile and Main Business
Table 45. BRF Ingredients Bioactive Protein and Peptides Models, Specifications, and Application
Table 46. BRF Ingredients Bioactive Protein and Peptides Revenue and Gross Margin, US$ Million, 2018-2023
Table 47. BRF Ingredients Recent Developments
Table 48. Bunge Ltd Company Information, Head Office, Market Area and Industry Position
Table 49. Bunge Ltd Company Profile and Main Business
Table 50. Bunge Ltd Bioactive Protein and Peptides Models, Specifications, and Application
Table 51. Bunge Ltd Bioactive Protein and Peptides Revenue and Gross Margin, US$ Million, 2018-2023
Table 52. Bunge Ltd Recent Developments
Table 53. Ingredia Nutritional Company Information, Head Office, Market Area and Industry Position
Table 54. Ingredia Nutritional Company Profile and Main Business
Table 55. Ingredia Nutritional Bioactive Protein and Peptides Models, Specifications, and Application
Table 56. Ingredia Nutritional Bioactive Protein and Peptides Revenue and Gross Margin, US$ Million, 2018-2023
Table 57. Ingredia Nutritional Recent Developments
Table 58. Gelatines Weishardt Company Information, Head Office, Market Area and Industry Position
Table 59. Gelatines Weishardt Company Profile and Main Business
Table 60. Gelatines Weishardt Bioactive Protein and Peptides Models, Specifications, and Application
Table 61. Gelatines Weishardt Bioactive Protein and Peptides Revenue and Gross Margin, US$ Million, 2018-2023
Table 62. Gelatines Weishardt Recent Developments
Table 63. PanTheryx Company Information, Head Office, Market Area and Industry Position
Table 64. PanTheryx Company Profile and Main Business
Table 65. PanTheryx Bioactive Protein and Peptides Models, Specifications, and Application
Table 66. PanTheryx Bioactive Protein and Peptides Revenue and Gross Margin, US$ Million, 2018-2023
Table 67. PanTheryx Recent Developments
Table 68. Hubei Reborn Biotech Company Information, Head Office, Market Area and Industry Position
Table 69. Hubei Reborn Biotech Company Profile and Main Business
Table 70. Hubei Reborn Biotech Bioactive Protein and Peptides Models, Specifications, and Application
Table 71. Hubei Reborn Biotech Bioactive Protein and Peptides Revenue and Gross Margin, US$ Million, 2018-2023
Table 72. Hubei Reborn Biotech Recent Developments
Table 73. Seagarden Company Information, Head Office, Market Area and Industry Position
Table 74. Seagarden Company Profile and Main Business
Table 75. Seagarden Bioactive Protein and Peptides Models, Specifications, and Application
Table 76. Seagarden Bioactive Protein and Peptides Revenue and Gross Margin, US$ Million, 2018-2023
Table 77. Seagarden Recent Developments
Table 78. Shandong Hengxin Biotech Company Information, Head Office, Market Area and Industry Position
Table 79. Shandong Hengxin Biotech Company Profile and Main Business
Table 80. Shandong Hengxin Biotech Bioactive Protein and Peptides Models, Specifications, and Application
Table 81. Shandong Hengxin Biotech Bioactive Protein and Peptides Revenue and Gross Margin, US$ Million, 2018-2023
Table 82. Shandong Hengxin Biotech Recent Developments
Table 83. Baotou Dongbao Bio-Tech Company Information, Head Office, Market Area and Industry Position
Table 84. Baotou Dongbao Bio-Tech Company Profile and Main Business
Table 85. Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Models, Specifications, and Application
Table 86. Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Revenue and Gross Margin, US$ Million, 2018-2023
Table 87. Baotou Dongbao Bio-Tech Recent Developments
Table 88. Wuhan Jiushengtang Biotech Company Information, Head Office, Market Area and Industry Position
Table 89. Wuhan Jiushengtang Biotech Company Profile and Main Business
Table 90. Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Models, Specifications, and Application
Table 91. Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Revenue and Gross Margin, US$ Million, 2018-2023
Table 92. Wuhan Jiushengtang Biotech Recent Developments
Table 93. Morinaga Milk Company Information, Head Office, Market Area and Industry Position
Table 94. Morinaga Milk Company Profile and Main Business
Table 95. Morinaga Milk Bioactive Protein and Peptides Models, Specifications, and Application
Table 96. Morinaga Milk Bioactive Protein and Peptides Revenue and Gross Margin, US$ Million, 2018-2023
Table 97. Morinaga Milk Recent Developments
Table 98. Collagile Company Information, Head Office, Market Area and Industry Position
Table 99. Collagile Company Profile and Main Business
Table 100. Collagile Bioactive Protein and Peptides Models, Specifications, and Application
Table 101. Collagile Bioactive Protein and Peptides Revenue and Gross Margin, US$ Million, 2018-2023
Table 102. Collagile Recent Developments
Table 103. Nuritas Company Information, Head Office, Market Area and Industry Position
Table 104. Nuritas Company Profile and Main Business
Table 105. Nuritas Bioactive Protein and Peptides Models, Specifications, and Application
Table 106. Nuritas Bioactive Protein and Peptides Revenue and Gross Margin, US$ Million, 2018-2023
Table 107. Nuritas Recent Developments
Table 108. SmartPEP Company Information, Head Office, Market Area and Industry Position
Table 109. SmartPEP Company Profile and Main Business
Table 110. SmartPEP Bioactive Protein and Peptides Models, Specifications, and Application
Table 111. SmartPEP Bioactive Protein and Peptides Revenue and Gross Margin, US$ Million, 2018-2023
Table 112. SmartPEP Recent Developments
List of Figures
Figure 1. Bioactive Protein and Peptides Picture
Figure 2. Global Bioactive Protein and Peptides Consumption Value, (US$ million) & (2018-2029)
Figure 3. China Bioactive Protein and Peptides Consumption Value, (US$ million) & (2018-2029)
Figure 4. By Consumption Value, China Bioactive Protein and Peptides Market Share of Global, 2018-2029
Figure 5. Global Bioactive Protein and Peptides Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 6. China Bioactive Protein and Peptides Key Participants, Market Share, 2022
Figure 7. Bioactive Protein and Peptides Industry Chain
Figure 8. Bioactive Protein and Peptides Procurement Model
Figure 9. Bioactive Protein and Peptides Sales Model
Figure 10. Bioactive Protein and Peptides Sales Channels, Direct Sales, and Distribution
Figure 11. Plant Source
Figure 12. Animal Source
Figure 13. By Source, Global Bioactive Protein and Peptides Consumption Value, 2018-2029, US$ Million
Figure 14. By Source, Global Bioactive Protein and Peptides Consumption Value Market Share, 2018-2029
Figure 15. Functional Food
Figure 16. Dietary Supplements
Figure 17. Personal Care
Figure 18. Animal Nutrition
Figure 19. Other
Figure 20. By Application, Global Bioactive Protein and Peptides Consumption Value, 2018-2029, US$ Million
Figure 21. By Application, Global Bioactive Protein and Peptides Consumption Value Market Share, 2018-2029
Figure 22. By Region, Global Bioactive Protein and Peptides Consumption Value Market Share, 2018-2029
Figure 23. North America Bioactive Protein and Peptides Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 24. By Country, North America Bioactive Protein and Peptides Consumption Value Market Share, 2022
Figure 25. Europe Bioactive Protein and Peptides Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 26. By Country, Europe Bioactive Protein and Peptides Consumption Value Market Share, 2022
Figure 27. Asia Pacific Bioactive Protein and Peptides Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 28. By Country/Region, Asia Pacific Bioactive Protein and Peptides Consumption Value Market Share, 2022
Figure 29. South America Bioactive Protein and Peptides Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 30. By Country, South America Bioactive Protein and Peptides Consumption Value Market Share, 2022
Figure 31. Middle East & Africa Bioactive Protein and Peptides Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 32. U.S. Bioactive Protein and Peptides Consumption Value, 2018-2029, US$ Million
Figure 33. By Source, U.S. Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
Figure 34. By Application, U.S. Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
Figure 35. Europe Bioactive Protein and Peptides Consumption Value, 2018-2029, US$ Million
Figure 36. By Source, Europe Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
Figure 37. By Application, Europe Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
Figure 38. China Bioactive Protein and Peptides Consumption Value, 2018-2029, US$ Million
Figure 39. By Source, China Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
Figure 40. By Application, China Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
Figure 41. Japan Bioactive Protein and Peptides Consumption Value, 2018-2029, US$ Million
Figure 42. By Source, Japan Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
Figure 43. By Application, Japan Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
Figure 44. South Korea Bioactive Protein and Peptides Consumption Value, 2018-2029, US$ Million
Figure 45. By Source, South Korea Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
Figure 46. By Application, South Korea Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
Figure 47. Southeast Asia Bioactive Protein and Peptides Consumption Value, 2018-2029, US$ Million
Figure 48. By Source, Southeast Asia Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
Figure 49. By Application, Southeast Asia Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
Figure 50. India Bioactive Protein and Peptides Consumption Value, 2018-2029, US$ Million
Figure 51. By Source, India Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
Figure 52. By Application, India Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
Figure 53. Middle East & Africa Bioactive Protein and Peptides Consumption Value, 2018-2029, US$ Million
Figure 54. By Source, Middle East & Africa Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
Figure 55. By Application, Middle East & Africa Bioactive Protein and Peptides Consumption Value Market Share, 2022 VS 2029
Figure 56. Research Methodology
Figure 57. Breakdown of Primary Interviews
Figure 58. Bottom-up and Top-down Approaches
Figure 59. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|